Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis

Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis

US Patent RE46856 · Granted May 22, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inh2025
Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors2024
Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhib2023
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors2023
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inh2022
Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhib2021
Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors2021
Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubi2021
Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors2021
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inh2021
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors2020
Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogen2020